397 related articles for article (PubMed ID: 36670699)
1. Diagnosis and Management of Cancer Treatment-Related Cardiac Dysfunction and Heart Failure in Children.
Hegazy M; Ghaleb S; Das BB
Children (Basel); 2023 Jan; 10(1):. PubMed ID: 36670699
[TBL] [Abstract][Full Text] [Related]
2. Cardio-Oncology in Childhood: State of the Art.
Bennati E; Girolami F; Spaziani G; Calabri GB; Favre C; Parrini I; Lucà F; Tamburini A; Favilli S
Curr Oncol Rep; 2022 Dec; 24(12):1765-1777. PubMed ID: 36181610
[TBL] [Abstract][Full Text] [Related]
3. Cardio-oncology: a multidisciplinary approach for detection, prevention and management of cardiac dysfunction in cancer patients.
Tajiri K; Aonuma K; Sekine I
Jpn J Clin Oncol; 2017 Aug; 47(8):678-682. PubMed ID: 28505345
[TBL] [Abstract][Full Text] [Related]
4. Novel approaches to the prediction, diagnosis and treatment of cardiac late effects in survivors of childhood cancer: a multi-centre observational study.
Skitch A; Mital S; Mertens L; Liu P; Kantor P; Grosse-Wortmann L; Manlhiot C; Greenberg M; Nathan PC
BMC Cancer; 2017 Aug; 17(1):519. PubMed ID: 28774277
[TBL] [Abstract][Full Text] [Related]
5. Pharmacotherapy for Cancer Treatment-Related Cardiac Dysfunction and Heart Failure in Childhood Cancer Survivors.
Das B
Paediatr Drugs; 2023 Nov; 25(6):695-707. PubMed ID: 37639193
[TBL] [Abstract][Full Text] [Related]
6. Cardio-oncology in Austria: cardiotoxicity and surveillance of anti-cancer therapies : Position paper of the Heart Failure Working Group of the Austrian Society of Cardiology.
Bergler-Klein J; Rainer PP; Wallner M; Zaruba MM; Dörler J; Böhmer A; Buchacher T; Frey M; Adlbrecht C; Bartsch R; Gyöngyösi M; Fürst UM
Wien Klin Wochenschr; 2022 Sep; 134(17-18):654-674. PubMed ID: 35507087
[TBL] [Abstract][Full Text] [Related]
7. Cardiac complications in childhood cancer survivors treated with anthracyclines.
Franco VI; Lipshultz SE
Cardiol Young; 2015 Aug; 25 Suppl 2():107-16. PubMed ID: 26377717
[TBL] [Abstract][Full Text] [Related]
8. Association of European Paediatric and Congenital Cardiology practical recommendations for surveillance and prevention of cardiac disease in childhood cancer survivors: the importance of physical activity and lifestyle changes From the Association of European Paediatric and Congenital Cardiology Working Group Sports Cardiology, Physical Activity and Prevention, Working Group Adult Congenital Heart Disease, Working Group Imaging and Working Group Heart Failure.
Kesting S; Giordano U; Weil J; McMahon CJ; Albert DC; Berger C; Budts W; Fritsch P; Hidvégi EV; Oberhoffer-Fritz R; Milano GM; Wacker-Gußmann A; Herceg-Čavrak V
Cardiol Young; 2024 Feb; 34(2):250-261. PubMed ID: 38174736
[TBL] [Abstract][Full Text] [Related]
9. Diagnosing Preclinical Cardiac Dysfunction in Swiss Childhood Cancer Survivors: Protocol for a Single-Center Cohort Study.
Schindera C; Kuehni CE; Pavlovic M; Haegler-Laube ES; Rhyner D; Waespe N; Roessler J; Suter T; von der Weid NX
JMIR Res Protoc; 2020 Jun; 9(6):e17724. PubMed ID: 32269016
[TBL] [Abstract][Full Text] [Related]
10. Cardiac Outcomes in Survivors of Pediatric and Adult Cancers.
Nathan PC; Amir E; Abdel-Qadir H
Can J Cardiol; 2016 Jul; 32(7):871-80. PubMed ID: 27179545
[TBL] [Abstract][Full Text] [Related]
11. Evaluation, prevention and management of cancer therapy-induced cardiotoxicity: a contemporary approach for clinicians.
Johnson CB; Sulpher J; Stadnick E
Curr Opin Cardiol; 2015 Mar; 30(2):197-204. PubMed ID: 25574894
[TBL] [Abstract][Full Text] [Related]
12. Rationale and design of the multidisciplinary team IntervenTion in cArdio-oNcology study (TITAN).
Pituskin E; Haykowsky M; McNeely M; Mackey J; Chua N; Paterson I
BMC Cancer; 2016 Sep; 16(1):733. PubMed ID: 27629548
[TBL] [Abstract][Full Text] [Related]
13. Role of cardiovascular imaging in cancer patients receiving cardiotoxic therapies: a position statement on behalf of the Heart Failure Association (HFA), the European Association of Cardiovascular Imaging (EACVI) and the Cardio-Oncology Council of the European Society of Cardiology (ESC).
Čelutkienė J; Pudil R; López-Fernández T; Grapsa J; Nihoyannopoulos P; Bergler-Klein J; Cohen-Solal A; Farmakis D; Tocchetti CG; von Haehling S; Barberis V; Flachskampf FA; Čeponienė I; Haegler-Laube E; Suter T; Lapinskas T; Prasad S; de Boer RA; Wechalekar K; Anker MS; Iakobishvili Z; Bucciarelli-Ducci C; Schulz-Menger J; Cosyns B; Gaemperli O; Belenkov Y; Hulot JS; Galderisi M; Lancellotti P; Bax J; Marwick TH; Chioncel O; Jaarsma T; Mullens W; Piepoli M; Thum T; Heymans S; Mueller C; Moura B; Ruschitzka F; Zamorano JL; Rosano G; Coats AJS; Asteggiano R; Seferovic P; Edvardsen T; Lyon AR
Eur J Heart Fail; 2020 Sep; 22(9):1504-1524. PubMed ID: 32621569
[TBL] [Abstract][Full Text] [Related]
14. Cardiotoxicity of anticancer treatments: Epidemiology, detection, and management.
Curigliano G; Cardinale D; Dent S; Criscitiello C; Aseyev O; Lenihan D; Cipolla CM
CA Cancer J Clin; 2016 Jul; 66(4):309-25. PubMed ID: 26919165
[TBL] [Abstract][Full Text] [Related]
15. Exercise Cardio-Oncology: Exercise as a Potential Therapeutic Modality in the Management of Anthracycline-Induced Cardiotoxicity.
Kang DW; Wilson RL; Christopher CN; Normann AJ; Barnes O; Lesansee JD; Choi G; Dieli-Conwright CM
Front Cardiovasc Med; 2021; 8():805735. PubMed ID: 35097024
[TBL] [Abstract][Full Text] [Related]
16. Cardio-oncology: an overview on outpatient management and future developments.
Teske AJ; Linschoten M; Kamphuis JAM; Naaktgeboren WR; Leiner T; van der Wall E; Kuball J; van Rhenen A; Doevendans PA; Cramer MJ; Asselbergs FW
Neth Heart J; 2018 Nov; 26(11):521-532. PubMed ID: 30141030
[TBL] [Abstract][Full Text] [Related]
17. Medical interventions for treating anthracycline-induced symptomatic and asymptomatic cardiotoxicity during and after treatment for childhood cancer.
Sieswerda E; van Dalen EC; Postma A; Cheuk DK; Caron HN; Kremer LC
Cochrane Database Syst Rev; 2011 Sep; (9):CD008011. PubMed ID: 21901716
[TBL] [Abstract][Full Text] [Related]
18. What Does a Cardio-oncology Service Offer to the Oncologist and the Haematologist?
Andres MS; Pan J; Lyon AR
Clin Oncol (R Coll Radiol); 2021 Aug; 33(8):483-493. PubMed ID: 33832839
[TBL] [Abstract][Full Text] [Related]
19. Cardiovascular Toxicities in Pediatric Cancer Survivors.
Ryan TD; Nagarajan R; Godown J
Cardiol Clin; 2019 Nov; 37(4):533-544. PubMed ID: 31587793
[TBL] [Abstract][Full Text] [Related]
20. Cardio-oncology issues among pediatric cancer and stem cell transplant survivors.
Hochberg JC; Cairo MS; Friedman DM
Cardiol Rev; 2014; 22(6):268-74. PubMed ID: 24926805
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
